Cargando…

Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common cause of dementia, typically showing progressive neurodegeneration in aging brains. The key signatures of the AD progression are the deposition of amyloid-beta (Aβ) peptides, the formation of tau tangles, and the induction of detrimental neuroinflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, You Jung, Diep, Yen N., Tran, Minh, Cho, Hansang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766709/ https://www.ncbi.nlm.nih.gov/pubmed/33339351 http://dx.doi.org/10.3390/ijms21249591

Ejemplares similares

Therapeutic nanoplatforms and delivery strategies for neurological disorders
por: Kang, You Jung, et al.
Publicado: (2018)

In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening
por: Ngo, Huyen, et al.
Publicado: (2023)

Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
por: Han, Sun-Ho, et al.
Publicado: (2014)

Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

The Protective Effects of Clams on Hypercholesterolemia in Late-Stage Triple-Transgenic Alzheimer’s Diseased Mice Hearts
por: Hsieh, You-Liang, et al.
Publicado: (2018)

Astrocytic scar restricting glioblastoma via glutamate–MAO-B activity in glioblastoma-microglia assembloid
por: Diep, Yen N., et al.
Publicado: (2023)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil
por: Park, Joseph, et al.
Publicado: (2019)

Human mini-blood–brain barrier models for biomedical neuroscience research: a review
por: Tran, Minh, et al.
Publicado: (2022)

Ethical Issues in the Treatment of Late-Stage Alzheimer’s Disease
por: Watt, Andrew D., et al.
Publicado: (2019)

Targeting prodromal Alzheimer’s disease: too late for prevention?
por: Yassine, Hussein N
Publicado: (2017)

Oral Pathogenic Bacteria-Inducing Neurodegenerative Microgliosis in Human Neural Cell Platform
por: Tran, Van Thi Ai, et al.
Publicado: (2021)

Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
por: Ortí-Casañ, Natalia, et al.
Publicado: (2019)

Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations
por: Maramai, Samuele, et al.
Publicado: (2020)

Functional Therapeutic Strategies Used in Different Stages of Alzheimer’s Disease—A Systematic Review
por: Olczak, Anna, et al.
Publicado: (2022)

Elucidating the Interactive Roles of Glia in Alzheimer's Disease Using Established and Newly Developed Experimental Models
por: Chun, Heejung, et al.
Publicado: (2018)

SORL1 mutations in early- and late-onset Alzheimer disease
por: Cuccaro, Michael L., et al.
Publicado: (2016)

Functional Connectivity of the Hippocampus in Early- and vs. Late-Onset Alzheimer's Disease
por: Park, Kee Hyung, et al.
Publicado: (2017)

Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Exosomes: a novel therapeutic target for Alzheimer’s disease?
por: Cai, Zhi-You, et al.
Publicado: (2018)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease
por: Ghosh, Shampa, et al.
Publicado: (2020)

TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment
por: Zhou, Yongji, et al.
Publicado: (2020)

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
por: Pires, Mariana, et al.
Publicado: (2023)

An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer’s Disease with Berberine and Palmatine
por: Zhao, Xin, et al.
Publicado: (2023)

Systemic infection modifies the neuroinflammatory response in late stage Alzheimer’s disease
por: Rakic, Sonja, et al.
Publicado: (2018)

Hippocampal LMNA Gene Expression is Increased in Late-Stage Alzheimer’s Disease
por: Méndez-López, Iván, et al.
Publicado: (2019)

Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer’s disease
por: Latimer, Caitlin S., et al.
Publicado: (2021)

SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late‐onset Alzheimer's disease
por: Jesudason, Cynthia D., et al.
Publicado: (2023)

An Air Particulate Pollutant Induces Neuroinflammation and Neurodegeneration in Human Brain Models
por: Kang, You Jung, et al.
Publicado: (2021)

The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease
por: Zhang, Li, et al.
Publicado: (2023)

Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
por: Lee, Wha Jin, et al.
Publicado: (2021)

Similar pattern of atrophy in early- and late-onset Alzheimer's disease
por: Eckerström, Carl, et al.
Publicado: (2018)

Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer’s Disease
por: Gil, Laura, et al.
Publicado: (2021)

Early-Life Environment Influence on Late-Onset Alzheimer’s Disease
por: Gauvrit, Thibaut, et al.
Publicado: (2022)

Thalamic nuclei changes in early and late onset Alzheimer's disease
por: Forno, Gonzalo, et al.
Publicado: (2023)

Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
por: Ju, Yaojun, et al.
Publicado: (2021)

Multipronged diagnostic and therapeutic strategies for Alzheimer's disease
por: Ramesh, Madhu, et al.
Publicado: (2022)

Effects of an early- and late-stage treatment with Geniposide on cognitive dysfunction in a transgenic mouse model relevant to Alzheimer's disease
por: Wang, Lei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7jjb8k95s5j9s2oigqg2u3psrd